Mounjaro Powers Eli Lilly to Bumper Quarter of Earnings

Markets & Money Today | 2 Min News | The Daily News Now! - Podcast tekijän mukaan The Daily News Now! - Torstaisin

kokeile Podimo ilmaiseksi 90!!! päivän ajan

kokeile Podimo ilmaiseksi 90!!! päivän ajan

universumia joka on täynnä satoja podcasteja ja äänikirjoja, klikkaa tätä kokeillaksesi

 Sponsored
Podcast artwork

Kategoriat:

Talous

Eli Lilly's Q3 profit surges due to soaring demand for weight-loss drugs Mounjaro and Zepbound, driving a 54% revenue increase and sending shares up 5%. The company is now a major player in the weight-loss drug market, with plans to launch a new pill and partner with Nvidia for AI-powered innovation.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Visit the podcast's native language site